Tarsier Pharma, Ltd, a late-clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of blinding ocular diseases, has appointed Ashley Kline as Chief Commercial Officer, a role that she will hold on a fractional basis as the company completes its late-stage clinical trials. Experience Kline brings extensive experience across multiple ophthalmic indications. In her new role, she will lead commercial planning for Tarsier’...